BTG Sentry

Unique Frame

  • Cylindrical Nitinol frame designed to minimize migration, perforation, embolization, and tilt
  • Self-expanding filter cone formed by 6 arms held centrally by a bioabsorbable filament2
  • Self-centering filtering cone is designed to reduce the risk of tilting and thereby maximizes filtration capacity

Bioconvertible Design

  • Designed to automatically bioconvert with arms retracting to the IVC wall after the period of transient risk (approximately 60 days)1, providing protection when you need it3-16
  • Bioconversion process leaves a patent lumen2
  • Eliminates the requirement, cost, and risk associated with IVC filter retrieval
  • Click here to view the BTG Sentry Animation Video

Proven Results

  • The prospective multicenter SENTRY study demonstrated a high level of safety and effectiveness
  • The trial established 100% freedom from new symptomatic PEs through 12 months, while typical published rates of symptomatic PEs range from 0.5 – 6%17
  • Eliminates the requirement, cost, and risk associated with IVC filter retrieval

Click here for the BTG Sentry Clinical Data

BTG Sentry In-Service

Contact

For BTG Sentry IVC Filter - Product Ordering, Technical Support, or Product Concerns, please contact 1.888.400.3567 or sentry.support@btgplc.com